Clinical Trial Update: COBRA PZF™ Coronary Stent for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term DAPT [NA]

View source ↗

Summary

Clinical trial update for the COBRA PZF coronary stent completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• COBRA PZF

Snippet

Sponsor: CeloNova BioSciences, Inc. | Conditions: Coronary Artery Disease | NA | Status: COMPLETED | Results posted: 2021-12-22